Iodine-131--metaiodobenzylguanidine double infusion with autologous stem-cell rescue for neuroblastoma: a new approaches to neuroblastoma therapy phase I study.
about
Feasibility of Administering High-Dose (131) I-MIBG Therapy to Children with High-Risk Neuroblastoma Without Lead-Lined Rooms.Safety and efficacy of tandem 131I-metaiodobenzylguanidine infusions in relapsed/refractory neuroblastoma.Toxicity of upfront ¹³¹I-metaiodobenzylguanidine (¹³¹I-MIBG) therapy in newly diagnosed neuroblastoma patients: a retrospective analysisPhase I/II study of (131)I-MIBG with vincristine and 5 days of irinotecan for advanced neuroblastomaImpact of Whole-Body Radiation Dose on Response and Toxicity in Patients With Neuroblastoma After Therapy With 131 I-Metaiodobenzylguanidine (MIBG).Arsenic Trioxide as a Radiation Sensitizer for 131I-Metaiodobenzylguanidine Therapy: Results of a Phase II Study.Phase I trial of fenretinide delivered orally in a novel organized lipid complex in patients with relapsed/refractory neuroblastoma: a report from the New Approaches to Neuroblastoma Therapy (NANT) consortium.Criteria for evaluation of disease extent by (123)I-metaiodobenzylguanidine scans in neuroblastoma: a report for the International Neuroblastoma Risk Group (INRG) Task Force.Thyroid and hepatic function after high-dose 131 I-metaiodobenzylguanidine (131 I-MIBG) therapy for neuroblastoma.Nothing but NET: a review of norepinephrine transporter expression and efficacy of 131I-mIBG therapyNeuroblastoma-targeted nanoparticles entrapping siRNA specifically knockdown ALK.Tumor dosimetry using [124I]m-iodobenzylguanidine microPET/CT for [131I]m-iodobenzylguanidine treatment of neuroblastoma in a murine xenograft model.Promising therapeutic targets in neuroblastomaAn evaluation in vitro of PARP-1 inhibitors, rucaparib and olaparib, as radiosensitisers for the treatment of neuroblastoma.Different outcomes for relapsed versus refractory neuroblastoma after therapy with (131)I-metaiodobenzylguanidine ((131)I-MIBG)Iodine-131-meta-iodobenzylguanidine therapy for patients with newly diagnosed high-risk neuroblastoma.Radiolabeled metaiodobenzylguanidine for the treatment of neuroblastomaComparison of iodine-123 metaiodobenzylguanidine (MIBG) scan and [18F]fluorodeoxyglucose positron emission tomography to evaluate response after iodine-131 MIBG therapy for relapsed neuroblastoma.High-risk neuroblastoma: a therapy in evolution.Radionuclide therapy of adrenal tumors.Ten challenges in the management of neuroblastoma.Ifosfamide, carboplatin, and etoposide for neuroblastoma: a high-dose salvage regimen and review of the literature.131I-MIBG followed by consolidation with busulfan, melphalan and autologous stem cell transplantation for refractory neuroblastoma.Acute changes in blood pressure in patients with neuroblastoma treated with ¹³¹I-metaiodobenzylguanidine (MIBG).Emerging drugs for neuroblastoma.Clinical research on rare diseases of children: neuroblastoma.Revisions to the International Neuroblastoma Response Criteria: A Consensus Statement From the National Cancer Institute Clinical Trials Planning Meeting.Tandem high-dose chemotherapy with thiotepa and busulfan-melphalan and autologous stem cell transplantation in very high-risk neuroblastoma patients.Dosimetric results in treatments of neuroblastoma and neuroendocrine tumors with (131)I-metaiodobenzylguanidine with implications for the activity to administer.5-day/5-drug myeloablative outpatient regimen for resistant neuroblastoma.Norepinephrine Transporter as a Target for Imaging and Therapy.Iodine-131 metaiodobenzylguanidine therapy for neuroblastoma: reports so far and future perspective.
P2860
Q30730580-FDF54E08-8C16-4D4B-82B9-125C1D70FDDFQ33394925-4158CC8D-7794-42CC-9E3E-6A6380DB40CEQ33409568-45EAAB5E-3A69-4A2C-9B6D-270ACF0B96CBQ33419875-C9AE7F9E-D241-4B91-BC46-2D1B31E9B0B5Q33427090-64D9FAFD-7D06-4C21-AFE7-7FA418CA61F5Q33428982-F3F9BCE7-6AF5-4A4F-B893-6FFE8D32B0A5Q33791667-17957822-2204-469A-B142-D00ACFAE68C7Q33834340-55BD70FC-5B23-4E00-8EC7-798B41E5B6A1Q34424834-849A9F16-6929-4E28-91B2-19E7C8ABC9C9Q34543646-6EB6DF36-B486-47CC-B549-F7CF613F4E49Q35086721-C7207080-465C-4BAE-A49E-98013F47D88AQ36013113-C65408F9-3995-4F4C-A28E-815422634738Q36055313-EE0C297F-98D6-4A95-8577-41D4ED687674Q36102008-CB7AD42B-F69B-4DC5-B0FE-BA80E86AAAC3Q36167173-D72146C2-60B9-4DB7-B887-617FF9F5F2C0Q36353230-644319A6-A8E0-4FDF-8B32-EAB620408B80Q37078231-8E4D7065-39EB-4BBB-B445-CA481C099437Q37411657-47EA2C86-8BE9-426A-A135-B9C89932E5BBQ37642871-EF341AF5-084F-4761-A682-CDBD5629B00CQ38020428-33254853-6AEF-4FB5-8352-6FE696DCAB1CQ38029366-310EC1CD-BF95-492F-84C0-82AC2DFAE66AQ38041019-64BB6EB6-9C4D-4A9A-8B2B-FAF6082FC463Q38048241-96D86AE2-FD69-4194-82F8-1C1FAE588B00Q38101306-8F967B56-95BD-48D1-B5E2-2B7A3852D292Q38108399-7D058BF6-C7DD-425A-BDCB-B1243578C344Q38791761-1354DCB0-0514-4C8C-8881-E287A7F127B4Q38804821-CCBC0C0C-25ED-4743-994F-1E93334921AEQ40367223-504487A4-A645-4D81-9186-CE37A8086E34Q40777229-B19A4424-7586-435E-B72D-7E9C8BFE3EA6Q44260246-E2CF21CD-DAE2-46FA-929F-0FBB404014E6Q47867820-7C9BF934-84B2-4C30-AAEE-806E74499C83Q51125396-C5A908F6-6AAC-4402-AEFA-12D93B72357A
P2860
Iodine-131--metaiodobenzylguanidine double infusion with autologous stem-cell rescue for neuroblastoma: a new approaches to neuroblastoma therapy phase I study.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 26 January 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Iodine-131--metaiodobenzylguan ...... lastoma therapy phase I study.
@en
Iodine-131--metaiodobenzylguan ...... lastoma therapy phase I study.
@nl
type
label
Iodine-131--metaiodobenzylguan ...... lastoma therapy phase I study.
@en
Iodine-131--metaiodobenzylguan ...... lastoma therapy phase I study.
@nl
prefLabel
Iodine-131--metaiodobenzylguan ...... lastoma therapy phase I study.
@en
Iodine-131--metaiodobenzylguan ...... lastoma therapy phase I study.
@nl
P2093
P2860
P356
P1476
Iodine-131--metaiodobenzylguan ...... lastoma therapy phase I study.
@en
P2093
Alekist Quach
Benjamin L Franc
Gregory Yanik
Hollie Jackson
Janet Veatch
John Huberty
John M Maris
Judith G Villablanca
Katherine K Matthay
Patricia Brophy
P2860
P304
P356
10.1200/JCO.2007.15.7628
P407
P577
2009-01-26T00:00:00Z